📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Vi polysaccharide and conjugated vaccines afford similar early, IgM or IgG-independent control of infection but boosting with conjugated Vi vaccines sustains the efficacy of immune responses. (2023)

First Author: Jossi SE

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2023.1139329

PubMed Identifier: 37033932

Publication URI: http://europepmc.org/abstract/MED/37033932

Type: Journal Article/Review

Volume: 14

Parent Publication: Frontiers in immunology

ISSN: 1664-3224